Sidiqi, M. Hasib
Aljama, Mohammed A.
Muchtar, Eli http://orcid.org/0000-0003-2210-2174
Buadi, Francis K.
Warsame, Rahma
Lacy, Martha Q.
Dispenzieri, Angela
Dingli, David
Leung, Nelson http://orcid.org/0000-0002-5651-1411
Gonsalves, Wilson I.
Kapoor, Prashant
Kourelis, Taxiarchis V.
Hogan, William J. http://orcid.org/0000-0002-5841-4105
Wolf, Robert C.
Kumar, Shaji K. http://orcid.org/0000-0001-5392-9284
Gertz, Morie A.
Funding for this research was provided by:
Spectrum Pharmaceuticals, Inc., Irvine, CA, USA
Article History
Received: 10 August 2018
Revised: 26 September 2018
Accepted: 19 October 2018
First Online: 2 November 2018
Compliance with ethical standards
:
: MAG received consultancy from Millenium and honoraria from Celgene, Millenium, Onyx, Novartis, SmithKline, Prothena, Ionis, and Amgen. SKK received consultancy from Celgene, Millennium, Onyx, Janssen, and BMS and research funding from Celgene, Millennium, Novartis, Onyx AbbVie, Janssen, and BMS. MQL received research funding from Celgene. DD received research funding from Karyopharm Therapeutics, and Millenium Pharmaceuticals. PK received research funding from Takeda, Celgene, and Amgen. AD received research funding from Celgene, Millennium, Pfizer, and Janssen and travel grant from Pfizer. The remaining authors declare that they have no conflict of interest.